The diagnosis of human T-cell leukemia virus type-1 (HTLV-1) infection has been widely
examined by serologics. In the first screening tests, serological false negative and positive …

Background Recently, J apanese R ed C ross blood centers have changed the confirmatory
test method from an indirect immunofluorescence (IF) technique to W estern blotting (WB) for …

Background The reliable diagnosis of human T-cell leukemia virus type 1 (HTLV-1) infection
is important, particularly as it can be vertically transmitted by breast feeding mothers to their …

Serological screening for human T-cell lymphotropic virus type 1 (HTLV-1) is usually
performed using enzyme-linked immunosorbent assay (ELISA), particle agglutination, or …

As the first US FDA-approved assay for supplemental HTLV testing, the MP Diagnostics
HTLV Blot 2.4 is an effective and efficient method for confirming and differentiating HTLV …

Laboratory testing for Human T‐lymphotropic Virus type 1 and 2 (HTLV‐1 and‐2) infections
has become routine in blood transfusion, tissue transplantation and clinical diagnoses in …

Background Human T-cell leukemia virus type 1 (HTLV-1) is a blood-borne virus, and
mandatory testing of donated blood for HTLV-1 antibodies has been adopted by Japanese …

In recent years a variety of studies have been carried out to compare the accuracy (generally
expressed in terms of sensitivity and specificity) of commercially available anti-HTLV tests …

The recommended algorithm for detection and characterization of serum human T-cell
lymphotropic virus (HTLV) antibodies calls for first performing a screening enzyme …

Brazil currently has the highest number of individuals infected with human T-lymphotropic
virus 1-and 2-(HTLV-1 and HTLV-2) globally. At present, neither molecular protocols nor …